🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Mohamed Cissé

ORCID: 0000-0002-6859-8745

Also affiliated with Gamal Abdel Nasser University of Conakry

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Dolutegravir plus boosted darunavir versus recommended standard-of-care antiretroviral regimens in people with HIV-1 for whom recommended first-line non-nucleoside reverse transcriptase inhibitor therapy has failed (D2EFT): an open-label, randomised, phase 3b/4 trial”.

Dolutegravir plus boosted darunavir versus recommended standard-of-care antiretroviral regimens in people with HIV-1 for whom recommended first-line non-nucleoside reverse transcriptase inhibitor therapy has failed (D2EFT): an open-label, randomised, phase 3b/4 trial

The Lancet HIV(2024)10.1016/s2352-3018(24)00089-4

N/A

1.0DataRank · unranked

31 citations

Simone Jacoby, Margaret Borok, Nnakelu Eriobu, Richard Kaplan, Nagalingeswaran Kumarasamy +32 more

Associations Between Antiretroviral Regimen and Changes in Blood Pressure: Results From the D2EFT Study

Clinical Infectious Diseases(2024)10.1093/cid/ciae256

N/A

0.505DataRank · unranked

10 citations

Kathy Petoumenos, Margaret Borok, Nnakelu Eriobu, Nagalingeswaran Kumarasamy, Anchalee Avihingsanon +7 more

Adaption of an ongoing clinical trial to quickly respond to gaps in changing international recommendations: the experience of D 2 EFT

HIV Research & Clinical Practice(2022)10.1080/25787489.2022.2103572

N/A

0DataRank · unranked

7 citations

Simone Jacoby, Dona Arlinda, Anchalee Avihingsanon, Iskandar Azwa, Margaret Borok +19 more

A Randomized Trial to Compare Dolutegravir Plus Boosted Darunavir Versus Recommended Standard of Care Antiretroviral Regimens in People With HIV-1, Whose First-line Non-nucleoside Reverse Transcriptase Inhibitor Therapy Has Failed: Final 96-week Results of the D2EFT Study

Clinical Infectious Diseases(2025)10.1093/cid/ciaf346

N/A

0DataRank · unranked

2 citations

Margaret Borok, Nnakelu Eriobu, Richard Kaplan, Nagalingeswaran Kumarasamy, Anchalee Avihingsanon +44 more